Cargando…

Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study

OBJECTIVE: Preliminary data indicate that predominant positive symptoms are predictive of subsequent treatment response, while negative and cognitive symptoms are associated with poor outcome. Purpose of the present study was to investigate the relation between the predominant clinical dimension, du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buoli, Massimiliano, Caldiroli, Alice, Panza, Gabriele, Altamura, Alfredo Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521111/ https://www.ncbi.nlm.nih.gov/pubmed/23251199 http://dx.doi.org/10.4306/pi.2012.9.4.354

Ejemplares similares

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine
por: Buoli, Massimiliano, et al.
Publicado: (2013)

Experimental Serotonergic Agents for the Treatment of Schizophrenia
por: Capuzzi, Enrico, et al.
Publicado: (2021)

Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study
por: Caldiroli, Alice, et al.
Publicado: (2018)

Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report
por: Grassi, Silvia, et al.
Publicado: (2017)

Duloxetine in Affective Disorders: a Naturalistic Study on Psychiatric and Medical Comorbidity, Use in Association and Tolerability Across Different Age Groups
por: Dell’Osso, Bernardo, et al.
Publicado: (2012)

Symptom Dimensions as Predictors of Clinical Outcome, Duration of Hospitalization, and Aggressive Behaviours in Acutely Hospitalized Patients with Psychotic Exacerbation
por: Colasanti, Alessandro, et al.
Publicado: (2010)

Sociodemographic and clinical characteristics associated with delirium in hospitalized patients with COVID-19: are immigrants a vulnerable group?
por: Capuzzi, Enrico, et al.
Publicado: (2023)

The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data
por: Buoli, Massimiliano, et al.
Publicado: (2017)

Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2022)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

A case of severe psychosis induced by novel recreational drugs
por: Dragogna, Filippo, et al.
Publicado: (2014)

Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: results from a Department of Mental Health and Addiction of northern Italy
por: Capuzzi, Enrico, et al.
Publicado: (2020)

Duration of untreated illness in panic disorder: a poor outcome risk factor?
por: Altamura, A Carlo, et al.
Publicado: (2005)

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset
por: Dell’Osso, Bernardo, et al.
Publicado: (2009)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021)

High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders
por: Auxilia, Anna Maria, et al.
Publicado: (2023)

Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review
por: Caldiroli, Alice, et al.
Publicado: (2023)

Does the Duration of the Illness Affect the Severity of Negative Symptoms of Schizophrenia?
por: Becarevic, Nejra, et al.
Publicado: (2022)

Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample
por: Caldiroli, Alice, et al.
Publicado: (2022)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features
por: Capuzzi, Enrico, et al.
Publicado: (2022)

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
por: Dell’Osso, Bernardo, et al.
Publicado: (2013)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Combined influence of illness duration and medication type on visual sensitivity in schizophrenia
por: Almeida, Natalia L., et al.
Publicado: (2019)

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes
por: Pungor, Katalin, et al.
Publicado: (2020)

Delirium in COVID-19 hospitalized patients: sociodemographic and clinical correlates in a small cohort of patients in Northern Italy
por: Cella, F., et al.
Publicado: (2022)

Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
por: Berendsen, Steven, et al.
Publicado: (2020)

Latent Clinical-Anatomical Dimensions of Schizophrenia
por: Kirschner, Matthias, et al.
Publicado: (2020)

Clinical and Peripheral Biomarkers in Female Patients Affected by Anorexia: Does the Neutrophil/Lymphocyte Ratio (NLR) Affect Severity?
por: Caldiroli, Alice, et al.
Publicado: (2023)

Personality dimensions of schizophrenia patients compared to control subjects by gender and the relationship with illness severity
por: Miralles, Carmen, et al.
Publicado: (2014)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population
por: Janno, Sven, et al.
Publicado: (2005)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment
por: Tompsett, Tamara, et al.
Publicado: (2018)

Processing of Spatial-Frequency Altered Faces in Schizophrenia: Effects of Illness Phase and Duration
por: Silverstein, Steven M., et al.
Publicado: (2014)

The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects
por: Hashimoto, Naoki, et al.
Publicado: (2017)

Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in Depression
por: Peitl, Vjekoslav, et al.
Publicado: (2020)

S84. EFFECTS OF COGNITIVE REHABILITATION AND ILLNESS DURATION ON VERBAL MEMORY AND LEARNING IN SCHIZOPHRENIA
por: Kontis, Dimitrios, et al.
Publicado: (2020)

Statistical determinants of visuomotor adaptation along different dimensions during naturalistic 3D reaches
por: Ferrea, E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lk6sdtkp2g8k4v15k17je4spls